Related Experiment Video
Updated: Sep 28, 2025
04:57
Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
10.4K
Estimating and Extrapolating Survival Using a State-Transition Modeling Approach: A Practical Application in Multiple
Istvan Majer1, Sonja Kroep2, Rana Maroun1
1Global Value and Access, Health Economics and Outcomes Research, Amgen (Europe) GmbH, Rotkreuz, Switzerland.
Summary
State-transition models (STMs) improve oncology survival predictions by accurately modeling postprogression survival. This study demonstrates STMs
Area of Science:
- Oncology
- Mathematical Modeling
- Survival Analysis
Background:
- State-transition models (STMs) in oncology have historically limited consideration for postprogression survival data.
- Accurate modeling of postprogression survival is crucial for reliable long-term survival predictions in cancer patients.
Purpose of the Study:
- To apply a state-transition model (STM) focusing on methods to evaluate postprogression transitions.
- To assess the impact of postprogression events on overall survival predictions in oncology.
Main Methods:
- Utilized data from the lenalidomide plus dexamethasone arm of the ASPIRE trial to estimate STM transition rates.
- Incorporated competing risks of progression and preprogression death, linking time to progression with subsequent mortality.
- Employed discrete event simulation to estimate progression-free and overall survival over 30 years.
Main Results:
- Modeled transition rates using piecewise exponential and exponential functions, capturing nonlinear effects of time to progression.
- The STM demonstrated survival estimates that closely fitted observed trial data.
- STM predictions showed more plausible long-term survival estimates compared to a conventional partitioned survival analysis (Weibull model).
Conclusions:
- The STM's strong fit indicates accurate capture of the underlying disease process.
- The study's approach may enhance the application of STMs in various oncology settings.
- Facilitates wider adoption of STMs for improved survival prediction in cancer research.
Keywords:
economic evaluationextrapolationmultiple myelomamultistate modeloncologystate-transition modelsurvival analysisMore Related Videos
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
400
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
8.7K
Related Concept Videos
01:24Kaplan-Meier Approach
288
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
288
01:21Cancer Survival Analysis
472
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
472
01:20Actuarial Approach
141
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
141
01:20Comparing the Survival Analysis of Two or More Groups
321
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
321
01:18Introduction To Survival Analysis
422
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
422
01:15Assumptions of Survival Analysis
204
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
204